AAAAAA

   
Results: 1-23 |
Results: 23
TIME-RESOLVED N-2 TRIPLET-STATE VIBRATIONAL POPULATIONS AND EMISSIONSASSOCIATED WITH RED SPRITES
Authors: MORRILL JS BUCSELA EJ PASKO VP BERG SL HEAVNER MJ MOUDRY DR BENESCH WM WESCOTT EM SENTMAN DD
Citation: Js. Morrill et al., TIME-RESOLVED N-2 TRIPLET-STATE VIBRATIONAL POPULATIONS AND EMISSIONSASSOCIATED WITH RED SPRITES, Journal of atmospheric and solar-terrestrial physics, 60(7-9), 1998, pp. 811-829
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHARMACOKINETICS OF O-6-BENZYLGUANINE AND ITS ACTIVE METABOLITE 8-OXO-O-6-BENZYLGUANINE IN PLASMA AND CEREBROSPINAL-FLUID AFTER INTRATHECALADMINISTRATION OF O-6-BENZYLGUANINE IN THE NONHUMAN PRIMATE
Authors: BERG SL MURRY DJ MCCULLY CL GODWIN K BALIS FM
Citation: Sl. Berg et al., PHARMACOKINETICS OF O-6-BENZYLGUANINE AND ITS ACTIVE METABOLITE 8-OXO-O-6-BENZYLGUANINE IN PLASMA AND CEREBROSPINAL-FLUID AFTER INTRATHECALADMINISTRATION OF O-6-BENZYLGUANINE IN THE NONHUMAN PRIMATE, Clinical cancer research, 4(11), 1998, pp. 2891-2894
PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS
Authors: BERG SL BLANEY SM ADAMSON PC OBRIEN M POPLACK DG ARNDT C BLATT J BALIS FM
Citation: Sl. Berg et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF PYRAZOLOACRIDINE IN CHILDREN AND YOUNG-ADULTS WITH REFRACTORY CANCERS, Journal of clinical oncology, 16(1), 1998, pp. 181-186
PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL
Authors: BLANEY SM SEIBEL NL OBRIEN M REAMAN GH BERG SL ADAMSON PC POPLACK DG KRAILO MD MOSHER R BALIS FM
Citation: Sm. Blaney et al., PHASE-I TRIAL OF DOCETAXEL ADMINISTERED AS A 1-HOUR INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE AND CHILDRENS CANCER GROUP TRIAL, Journal of clinical oncology, 15(4), 1997, pp. 1538-1543
PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE IN COMBINATION WITH INTERFERON-ALPHA-2A IN PEDIATRIC-PATIENTS WITH REFRACTORY CANCER
Authors: ADAMSON PC REAMAN G FINKLESTEIN JZ FEUSNER J BERG SL BLANEY SM OBRIEN M MURPHY RF BALIS FM
Citation: Pc. Adamson et al., PHASE-I TRIAL AND PHARMACOKINETIC STUDY OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE IN COMBINATION WITH INTERFERON-ALPHA-2A IN PEDIATRIC-PATIENTS WITH REFRACTORY CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3330-3337
STATUS OF NEW ANTHRAPYRAZOLE AND PYRAZOLOACRIDINE DERIVATIVES
Authors: BERG SL
Citation: Sl. Berg, STATUS OF NEW ANTHRAPYRAZOLE AND PYRAZOLOACRIDINE DERIVATIVES, Critical reviews in oncology/hematology, 22(2), 1996, pp. 79-87
PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: TOLCHER AW COWAN KH SOLOMON D OGNIBENE F GOLDSPIEL B CHANG R NOONE MH DENICOFF AM BARNES CS GOSSARD MR FETSCH PA BERG SL BALIS FM VENZON DJ OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1173-1184
RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN
Authors: WEXLER LH ANDRICH MP VENZON D BERG SL WEAVERMCCLURE L CHEN CC DILSIZIAN V AVILA N JAROSINSKI P BALIS FM POPLACK DG HOROWITZ ME
Citation: Lh. Wexler et al., RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN, Journal of clinical oncology, 14(2), 1996, pp. 362-372
PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS
Authors: BLANEY SM PHILLIPS PC PACKER RJ HEIDEMAN RL BERG SL ADAMSON PC ALLEN JC SALLAN SE JAKACKI RL LANGE BJ REAMAN GH HOROWITZ ME POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II EVALUATION OF TOPOTECAN FOR PEDIATRIC CENTRAL-NERVOUS-SYSTEMTUMORS, Cancer, 78(3), 1996, pp. 527-531
CYTOTOXICITY AND DNA-DAMAGE ASSOCIATED WITH PYRAZOLOACRIDINE IN MCF-7BREAST-CANCER CELLS
Authors: GREM JL POLITI PM BERG SL BENCHEKROUN NM PATEL M BALIS FM SINHA BK DAHUT W ALLEGRA CJ
Citation: Jl. Grem et al., CYTOTOXICITY AND DNA-DAMAGE ASSOCIATED WITH PYRAZOLOACRIDINE IN MCF-7BREAST-CANCER CELLS, Biochemical pharmacology, 51(12), 1996, pp. 1649-1659
ADVANCES IN THE TREATMENT OF MENINGEAL CANCERS
Authors: BERG SL POPLACK DG
Citation: Sl. Berg et Dg. Poplack, ADVANCES IN THE TREATMENT OF MENINGEAL CANCERS, Critical reviews in oncology/hematology, 20(1-2), 1995, pp. 87-98
EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER
Authors: BERG SL TOLCHER A OSHAUGHNESSY JA DENICOFF AM NOONE M OGNIBENE FP COWAN KH BALIS FM
Citation: Sl. Berg et al., EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER, Journal of clinical oncology, 13(8), 1995, pp. 2039-2042
PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF O-6-BENZYLGUANINE AND TIME-COURSE OF PERIPHERAL-BLOOD MONONUCLEAR CELL O-6-METHYLGUANINE-DNA METHYLTRANSFERASE INHIBITION IN THE NONHUMAN PRIMATE
Authors: BERG SL GERSON SL GODWIN K COLE DE LIU L BALIS FM
Citation: Sl. Berg et al., PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF O-6-BENZYLGUANINE AND TIME-COURSE OF PERIPHERAL-BLOOD MONONUCLEAR CELL O-6-METHYLGUANINE-DNA METHYLTRANSFERASE INHIBITION IN THE NONHUMAN PRIMATE, Cancer research, 55(20), 1995, pp. 4606-4610
A PHASE-I TRIAL OF AMIFOSTINE (WR-2721) AND MELPHALAN IN CHILDREN WITH REFRACTORY CANCER
Authors: ADAMSON PC BALLS FM BELASCO JE LANGE B BERG SL BLANEY SM CRAIG C POPLACK DG
Citation: Pc. Adamson et al., A PHASE-I TRIAL OF AMIFOSTINE (WR-2721) AND MELPHALAN IN CHILDREN WITH REFRACTORY CANCER, Cancer research, 55(18), 1995, pp. 4069-4072
PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION
Authors: BERG SL COWAN KH BALIS FM FISHERMAN JS DENICOFF AM HILLIG M POPLACK DG OSHAUGHNESSY JA
Citation: Sl. Berg et al., PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION, Journal of the National Cancer Institute, 86(2), 1994, pp. 143-145
TOXICITY OF INTRATHECAL MELPHALAN - REPLY
Authors: BERG SL BALIS FM MCCULLY CL POPLACK DG
Citation: Sl. Berg et al., TOXICITY OF INTRATHECAL MELPHALAN - REPLY, Journal of the National Cancer Institute, 86(11), 1994, pp. 871-871
PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/
Authors: WILSON WH BERG SL BRYANT G WITTES RE BATES S FOJO A STEINBERG SM GOLDSPIEL BR HERDT J OSHAUGHNESSY J BALIS FM CHABNER BA
Citation: Wh. Wilson et al., PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/, Journal of clinical oncology, 12(8), 1994, pp. 1621-1629
PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: SAVARESE DMF DENICOFF AM BERG SL HILLIG M BAKER SP OSHAUGHNESSY JA CHOW C OTTERSON GA BALIS FM POPLACK DG COWAN KH
Citation: Dmf. Savarese et al., PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 11(9), 1993, pp. 1795-1803
PHARMACOKINETICS OF PEG-L-ASPARAGINASE AND PLASMA AND CEREBROSPINAL-FLUID L-ASPARAGINE CONCENTRATIONS IN THE RHESUS-MONKEY
Authors: BERG SL BALIS FM MCCULLY CL GODWIN KS POPLACK DG
Citation: Sl. Berg et al., PHARMACOKINETICS OF PEG-L-ASPARAGINASE AND PLASMA AND CEREBROSPINAL-FLUID L-ASPARAGINE CONCENTRATIONS IN THE RHESUS-MONKEY, Cancer chemotherapy and pharmacology, 32(4), 1993, pp. 310-314
PHARMACOKINETICS, CEREBROSPINAL-FLUID PENETRATION, AND METABOLISM OF PIROXANTRONE IN THE RHESUS-MONKEY
Authors: BERG SL BALIS FM GODWIN KS POPLACK DG
Citation: Sl. Berg et al., PHARMACOKINETICS, CEREBROSPINAL-FLUID PENETRATION, AND METABOLISM OF PIROXANTRONE IN THE RHESUS-MONKEY, Investigational new drugs, 11(4), 1993, pp. 255-261
PHARMACOKINETICS OF PIROXANTRONE IN A PHASE-I TRIAL OF PIROXANTRONE AND GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: BERG SL SAVARESE DMF BALIS FM DENICOFF AM HILLIG M OSHAUGHNESSY JA POPLACK DG COWAN KH
Citation: Sl. Berg et al., PHARMACOKINETICS OF PIROXANTRONE IN A PHASE-I TRIAL OF PIROXANTRONE AND GRANULOCYTE-COLONY-STIMULATING FACTOR, Cancer research, 53(11), 1993, pp. 2587-2590
Risultati: 1-23 |